Advertisement

Annals of Nuclear Medicine

, Volume 2, Issue 1, pp 49–53 | Cite as

Increased accumulation of iodine-123-IMP in the pulmonary inflammatory lesion surrounding a lung cancer

  • Masayuki Nakajo
  • Noriaki Uchiyama
  • Yoshiyuki Hiraki
  • Yoshihiko Miyata
  • Atsuhisa Iriki
  • Yasunobu Hirotsu
  • Joeji Wakimoto
  • Yoshimasa Norimatsu
Case Report

Abstract

In a patient with primary lung cancer, increased accumulation of I-123-IMP was observed in a pulmonary inflammatory lesion surrounding a lung cancer which was delineated as a photon deficient area. Ga-67-citrate uptake was observed in both the inflammatory and cancerous areas. These findings suggest that I-123-IMP may have the potential to accumulate differently in a variety of pathological conditions of the lung and thus may be a clinically useful lung imaging agent.

Key words

I-123-IMP Lung imaging Pulmonary inflammation Lung cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Winchell HS, Baldwin RM, Lin TH: Development of I-123-labeled amines for brain studies: Localization of 1-123 iodophenylalkyl amines in rat brain.J Nucl Med 21: 940–946, 1980PubMedGoogle Scholar
  2. 2.
    Hill TC, Holman BL, Lovett R, et al: Initial experience with SPECT (Single-Photon Computerized Tomography) of the brain using N-isopropyl 1-123 P-iodoamphetamine: Concise communication.J Nucl Med 23: 191–195, 1982PubMedGoogle Scholar
  3. 3.
    Holman BL, Hill TC, Polak JF, et al: Cerebral perfusion imaging with iodine 123-labeled amines.Arch Neurol 41: 1060–1063, 1984PubMedGoogle Scholar
  4. 4.
    Coni NK, Wraight EP, Barber RW: Regional cerebral perfusion imaging in the elderly.Age and Aging 13: 214–217, 1984CrossRefGoogle Scholar
  5. 5.
    Gemmell HG, Sharp PF, Evans NTS, et al: Single photon emission tomography with 123I-isopropyl-amphetamine in Alzheimer’s disease and multi-infarct dementia.Lancet: 1348, December 8, 1984Google Scholar
  6. 6.
    Magistretti P, Uren R, Blume H, et al: Delineation of epileptic focus by single photon emission tomography.Eur J Nucl Med 7: 484–485, 1982PubMedCrossRefGoogle Scholar
  7. 7.
    Touya J, Akber SF, Rahimian J, et al: Metabolic lung scanning with N-isopropyl-I-123-p-iodoamphet-amine. In Nuclear Medicine and Biology, Volume 3, Raynaud C, (ed.), Paris, Pergamon Press, pp. 2554–2557, 1982Google Scholar
  8. 8.
    Touya JJ, Rahimian J, Grubbs DE, et al: A non-invasive procedure for in vivo assay of a lung amine endothelial receptor.J Nucl Med 26: 1302–1307, 1985PubMedGoogle Scholar
  9. 9.
    Watanabe N, Yokoyama K, Aburano T, et al: I-123-IMP as a new tumor affinity agent for malignant tumor.J Nucl Med 27: 1033, 1986Google Scholar
  10. 10.
    Secker-Walker, RH: The respiratory system. Textbook of Nuclear Medicine, Vol 2: Clinical applications, Harbert J, da Rocha AFG, eds, Philadelphia, Lea & Febiger, 1984, pp. 311–379Google Scholar
  11. 11.
    LaFrance ND, Wagner HN, Whitehouse Jr P, et al: Decreased accumulation of isopropyl-iodoamphet-amine (I-123) in brain tumors.J Nucl Med 22: 1081–1083, 1981PubMedGoogle Scholar
  12. 12.
    Larson SM, Camargo EE, Keenan AM: Tumors. Textbook of Nuclear Medicine, Vol 2: Clinical applications, Harbert J, da Rocha AFG, eds. Philadelphia, Lea & Febiger, 1984, pp. 635–662Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • Masayuki Nakajo
    • 1
  • Noriaki Uchiyama
    • 1
  • Yoshiyuki Hiraki
    • 1
  • Yoshihiko Miyata
    • 1
  • Atsuhisa Iriki
    • 1
  • Yasunobu Hirotsu
    • 1
  • Joeji Wakimoto
    • 1
  • Yoshimasa Norimatsu
    • 1
  1. 1.Department of Radiology, Respiratory Internal Medicine and SurgeryNational Minami-Kyushu HospitalKagoshimaJapan

Personalised recommendations